CME Group CEO Terry Duffy to transition to Executive Chairman in March 2027; President & CFO Lynne Fitzpatrick named CEO

CME GROUP INC.

Terrence A. Duffy will become Executive Chairman effective March 1, 2027 (or later when 2026 10-K is filed); he remains CEO until then.
Lynne C. Fitzpatrick, currently President and CFO, will succeed Duffy as CEO and join the Board on the transition date.
Fitzpatrick's CEO compensation: $1.2M base salary; annual bonus target 200% of base; LTI target 700% of base.
Company will conduct a search for a successor to Fitzpatrick as CFO.
Duffy's transition agreement provides continued base salary, bonus and equity vesting at target through his Executive Chairman term ending Dec 31, 2027.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lynne C. Fitzpatrick

Director

CME · CME GROUP INC.

Filed: June 17, 2026, 8:35 AM ET

Ms. Fitzpatrick will continue to serve as the Company’s President and Chief Financial Officer through the Transition Date and will then assume the role of Chief Executive Officer and be appointed to the Board and its Executive Committee on the Transition Date.

Role change

Lynne C. Fitzpatrick

Chief Executive Officer

CME · CME GROUP INC.

Filed: June 17, 2026, 8:35 AM ET

Lynne C. Fitzpatrick, the Company’s current President and Chief Financial Officer, will succeed Mr. Duffy as the Company’s Chief Executive Officer

Role change

Terrence A. Duffy

Executive Chairman

CME · CME GROUP INC.

Successor: Lynne C. Fitzpatrick
Filed: June 17, 2026, 8:35 AM ET

Terrence A. Duffy, the Company’s current Chairman and Chief Executive Officer, will become the Company’s Executive Chairman

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lynne C. Fitzpatrick was appointed as Director at CME GROUP INC..

Action: appointed
Role: Director

Exact text from the filing

Ms. Fitzpatrick will continue to serve as the Company’s President and Chief Financial Officer through the Transition Date and will then assume the role of Chief Executive Officer and be appointed to the Board and its Executive Committee on the Transition Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Lynne C. Fitzpatrick changed role as Chief Executive Officer at CME GROUP INC..

Action: succeed
Role: Chief Executive Officer

Exact text from the filing

Lynne C. Fitzpatrick, the Company’s current President and Chief Financial Officer, will succeed Mr. Duffy as the Company’s Chief Executive Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Terrence A. Duffy was appointed as Executive Chairman at CME GROUP INC..

Action: appointed
Role: Executive Chairman

Exact text from the filing

Terrence A. Duffy, the Company’s current Chairman and Chief Executive Officer, will become the Company’s Executive Chairman

View on SEC.gov

CME GROUP INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-273442

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.